Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson’s Disease in the Harvard Biomarkers Study-Reference-Cited by-同舟云学术

Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson’s Disease in the Harvard Biomarkers Study

Published:2020-04-03 Issue:2 Volume:10 Page:505-510
ISSN:1877-7171
Container-title:Journal of Parkinson's Disease
language:
Short-container-title:JPD

Author:

Bakshi Rachit¹²,Macklin Eric A.²³,Hung Albert Y.¹²,Hayes Michael T.²⁴,Hyman Bradley T.¹²,Wills Anne-Marie¹²,Gomperts Stephen N.¹²,Growdon John H.¹²,Ascherio Alberto³,Scherzer Clemens R.¹²⁴⁵,Schwarzschild Michael A.¹²

Affiliation:

1. Department of Neurology, Massachusetts General Hospital, Boston, MA, USA

2. Harvard Medical School, Boston, MA, USA

3. Biostatistics Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA

4. APDA Center for Advanced Parkinson Research, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

5. Precision Neurology Program, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Reference18 articles.

1. Epidemiology, environmental risk factors and genetics of Parkinson’s disease;Delamarre;Presse Med,2017

2. Environment, lifestyle, and Parkinson’s disease: Implications for prevention in the next decade;Marras;Mov Disord,2019

3. The epidemiology of Parkinson’s disease: Risk factors and prevention;Ascherio;Lancet Neurol,2016

4. Pathophysiological roles for purines: Adenosine, caffeine and urate;Morelli;Prog Brain Res,2010

5. Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker Study;Ding;Mov Disord,2011

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caffeine Consumption and Interaction with ADORA2A, CYP1A2 and NOS1 Variants Do Not Influence Age at Onset of Machado-Joseph Disease;The Cerebellum;2024-07-06

2. Dietary Caffeine and Brain Dopaminergic Function in Parkinson Disease;Annals of Neurology;2024-05-20

3. Diagnosing Parkinson’s disease and monitoring its progression: Biomarkers from combined GC-TOF MS and LC-MS/MS untargeted metabolomics;Heliyon;2024-05

4. Epidemiology of Parkinson’s Disease: An Update;Current Neurology and Neuroscience Reports;2024-04-20

5. Gene–Environment Interactions for Parkinson's Disease;Annals of Neurology;2024-01-12